Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Posted on 7 January 20207 January 2020 by Christine Laroche

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction
  • Darzalex Faspro (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
  • Enhertu Approved in the U.S. for the Treatment of Patients With Previously Treated HER2 Positive Advanced Gastric Cancer
  • Pfizer’s Xalkori (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults

RSS Pharma Manufacturing News

  • UAE gives approval for use of Sputnik V vaccine to combat Covid-19
  • In vitro study finds Pfizer, BioNTech’s vaccine could inhibit Covid-19 caused by UK strain
  • Akron Biotech to exclusively manufacture Human AB Serum for Octapharma

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • The Prescription for a Superior Healthcare Network
  • The Actively Connected Physician: How CMS Mandated ADT Event Notifications Lead to Improved Patient Care
  • Enterprise Imaging: See What You’ve Been Missing
  • Establishing Security for Cloud Healthcare Solutions
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok